Medical News

RSS

Disabling back pain increases mortality risk for older women

Disabling back pain puts women in their 70s at an increased risk of death, findings from the Cambridge City over-75s Cohort study suggest.

4 Aug 2014

NSAID use may mask early pneumonia symptoms

People with pneumococcal pneumonia who are taking nonsteroidal anti-inflammatory drugs at the point of diagnosis tend to develop more severe disease despite being younger and healthier than those not using these drugs, shows research.

4 Aug 2014

Hypertension control may ward off renal damage in diabetics

Elevated blood pressure is associated with an increased risk of renal damage in patients with Type 2 diabetes, especially if they have poor glycaemic control, study findings suggest.

4 Aug 2014

Preoperative urodynamics ‘has no added value’ in SUI patients

Preoperative urodynamic studies may be unnecessary in many women undergoing primary surgery for stress urinary incontinence, say the authors of a systematic review and meta-analysis.

4 Aug 2014

St. Joseph Hoag Health, CHOC Children's to jointly form accountable care organization

St. Joseph Hoag Health and CHOC Children's announced this morning that they will form an accountable care organization (ACO), bringing together outstanding health care providers throughout Orange County.

4 Aug 2014

Updated guidelines for prostate cancer survivorship care published in Journal of Men's Health

Many of the more than 2.5 million men in the U.S. who have received treatment for prostate cancer deal with the often disabling side effects of surgery and radiation and hormonal therapies.

4 Aug 2014

Research results in new insights into clinical depression

Research led by the University of Adelaide has resulted in new insights into clinical depression that demonstrate there cannot be a "one-size-fits-all" approach to treating the disease.

4 Aug 2014

New, promising approach combines metformin and SGLT2 inhibitors to treat diabetes

Various active substances in oral antidiabetic agents are frequently combined in the treatment of diabetes in order to achieve an effective reduction in the blood sugar. A new, very promising approach combines the substances metformin and SGLT2 inhibitors, the latter were just approved in 2012.

4 Aug 2014

5-LO enzyme plays important role in the survival of leukaemic AML stem cells

Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse.

4 Aug 2014

Study shows new potential mechanism to better understand AD in African Americans

Researchers from Boston University School of Medicine report that two rare variants in the AKAP9 gene significantly increase the risk of Alzheimer's disease (AD) in African-Americans.

4 Aug 2014

AMP publishes updated position statement on the regulation of LDPs

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.

4 Aug 2014

Newly insured get schooling on how to use coverage

Health law advocates who had focused on enrolling people in insurance now are teaching them how to use their often-complicated policies. Meanwhile, a Hartford physician explains why he won't take Obamacare plans and thousands of inmates in a Cook County jail sign up for insurance.

4 Aug 2014

onFocus Healthcare signs new contracts to expand customer base for onFocus|epm system

onFocus Healthcare, Inc., the leading provider of healthcare enterprise performance management solutions for the healthcare marketplace, today announced that it has signed a series of new contracts in the first half of 2014, growing the customer base for its onFocus|epm software by 152 hospitals.

4 Aug 2014

PCI agrees to acquire Penn Pharma

Packaging Coordinators, Inc. is pleased to announce it has finalized its agreement to acquire Penn Pharmaceutical Services Limited (Penn Pharma).

4 Aug 2014

Health insurer to stop covering uterine procedure

Highmark Inc., which sells plans in Pennsylvania, Delaware and West Virginia, will stop covering power morcellation, a technique often used in hysterectomies, after the Food and Drug Administration advised doctors against it because it may spread cancer.

4 Aug 2014

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).

4 Aug 2014

Neuralstem doses final patient with NSI-566 stem cells in Phase II trial

Neuralstem, Inc. announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

4 Aug 2014

Researchers at NIH-FEI Living Lab for Structural Biology achieve breakthrough biological results

FEI is pleased to announce that researchers at the NIH-FEI Living Lab for Structural Biology have achieved breakthrough biological results, using FEI’s Titan Krios™ transmission electron microscope (TEM), to elucidate the structural mechanism by which glutamate receptors participate in the transmission of signals between neurons in the brain. Their work is described in Nature, “Structural Mechanism of Glutamate Receptor Activation and Desensitization,” by Meyerson, et al., (DOI: 10.1038/nature13603), http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13603.html .

From Thermo Fisher Scientific – Electron Microscopy Solutions 4 Aug 2014

FDA clears ElMindA's BNA Analysis System for assessment of brain function

ElMindA Ltd. announced today that the United States Food and Drug Administration has cleared the company's BNA Analysis System for the assessment of brain function. Brain Network Activity (BNA) combines non-invasive, multi-channel EEG technology with sophisticated signal processing and analysis algorithms to measure patterns of brain networks activated during specific brain processes and deliver both quantitative and qualitative insights into brain functionality.

4 Aug 2014

Henry Schein net sales increase 9.3% to $2.6 billion in Q2 2014

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial results for the quarter ended June 28, 2014.

4 Aug 2014